Literature DB >> 11422484

Host ethnicity influences non-Hodgkin's lymphoma subtype frequency and Epstein-Barr virus association rate: the experience of a multi-ethnic patient population in Malaysia.

S C Peh1.   

Abstract

AIMS: The pattern of malignant lymphoma is known to vary in different populations. This study aims to elucidate the effect of ethnicity on subtype frequency of non-Hodgkin's lymphoma and EBV association rate. METHODS AND
RESULTS: A total of 232 reconfirmed lymphoma cases in Malaysian patients were retrieved from the archives in the Department of Pathology, University Hospital, Kuala Lumpur. There were 24 (10%) Hodgkin's and 208 (90%) non-Hodgkin's lymphomas, 173 of the latter were in adult group (aged > or = 15 years). The ethnic composition were 41 Malays, 107 Chinese, 21 Indians and four none of the above. A male : female ratio of 2.4 : 1 was observed. Complete immunohistochemical studies in 158 cases revealed 36 (23%) T-cell, 121 (76%) B-cell and one (1%) null-cell phenotype. Seventy-five percent of the T-cell lymphomas were peripheral T/NK-cell types. Among the classifiable lesions, low-grade/indolent lymphomas constituted 17%: 2% were the lymphocytic subtype and 10% were follicular lymphomas. Approximately one-third of the follicular lymphomas occurred in Indian patients. The largest group of high-grade lymphoma was diffuse large B-cell type (46%), followed by peripheral T/NK-cell (18%). A predominance of NK/T-cell lymphomas occurred in Chinese (5/7), and all were EBV associated. Burkitt's lymphoma accounted for 5% (eight cases), all were Chinese males, with a 38% EBV-association rate. The frequency of EBV-associated B-cell lymphoma is three times more common in Chinese than Malays. The EBV positivity rate among lymphomas in ethnic Malay, Chinese and Indian patients was 5%, 15% and 22%, respectively, and in T- and B-cell lymphomas was 36% and 7%, respectively.
CONCLUSIONS: This Malaysian series reveals differences in the subtype frequencies of non-Hodgkin's lymphomas and EBV association rate amongst patients of various ethnic groups residing in the same environment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422484     DOI: 10.1046/j.1365-2559.2001.01104.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  10 in total

1.  Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States.

Authors:  Jill Koshiol; Tram Kim Lam; Gloria Gridley; David Check; Linda Morris Brown; Ola Landgren
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

2.  Detection of Epstein-Barr virus in lower gastrointestinal tract lymphomas: a study in Malaysian patients.

Authors:  Asmah M Yunos; Hasnan Jaafar; Fauziah M Idris; Gurjeet Kaur; Mohamed J E M F Mabruk
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patients.

Authors:  A K H Shia; G-G Gan; S Jairaman; S-C Peh
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

4.  Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A.

Authors:  Kathryn T Bieging; Michelle Swanson-Mungerson; Alexandra C Amick; Richard Longnecker
Journal:  Cell Cycle       Date:  2010-03-03       Impact factor: 4.534

5.  Sinonasal Lymphoma Presenting as Cavernous Sinus Syndrome: Case Report and Review of the Literature.

Authors:  Noranida Abd Manan; May May Choo; Irina Effendi Tenang; Mimiwati Zahari
Journal:  Neuroophthalmology       Date:  2021-11-10

6.  Lymphomas in Ile-Ife, Nigeria: Immunohistochemical Characterization and Detection of Epstein-Barr virus Encoded RNA.

Authors:  Ifeyinwa M Onwubuya; Kayode A Adelusola; Muheez A Durosinmi; Donatus Sabageh; Kevin N Ezike
Journal:  J Clin Diagn Res       Date:  2015-06-01

Review 7.  The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.

Authors:  A A Gru; B H Haverkos; A G Freud; J Hastings; N B Nowacki; C Barrionuevo; C E Vigil; R Rochford; Y Natkunam; R A Baiocchi; P Porcu
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

8.  Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.

Authors:  Tamiwe Tomoka; Eric Powers; Toon van der Gronde; Amy Amuquandoh; Bal Mukunda Dhungel; Coxcilly Kampani; Steve Kamiza; Nathan D Montgomery; Yuri Fedoriw; Satish Gopal
Journal:  BMC Cancer       Date:  2017-09-06       Impact factor: 4.430

9.  Extranodal lymphoma arising within the maxillary alveolus: a systematic review.

Authors:  David MacDonald; Sean Lim
Journal:  Oral Radiol       Date:  2017-12-08       Impact factor: 1.852

Review 10.  EBV and the Pathogenesis of NK/T Cell Lymphoma.

Authors:  Ivonne A Montes-Mojarro; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Cancers (Basel)       Date:  2021-03-19       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.